Showing results (31-40 of 119) with videos related to

Sort By:
Pageof 12
International Journal of Molecular Sciences|July 29, 2025
Urinary Titin as a Non-Invasive Biomarker for Sarcopenia Sex Differences in Unresectable Digestive Malignancies: A Retrospective Cohort StudyShiho Kaneko, Kazuaki Harada, Masatsugu Ohara, et al.
Journal of Cancer Research and Clinical Oncology|May 9, 2025
Lack of association between SLFN11 expression and treatment efficacy or survival outcomes in patients with pancreatic ductal adenocarcinomaTakeaki Nakamura, Kanako C Hatanaka, Yasuyuki Kawamoto, et al.
Frontiers in Oncology|December 15, 2025
Ultrasound-detected gastric changes related to zolbetuximab-induced emesis: a case seriesKazuaki Harada, Koichi Ishida, Shiho Kaneko, et al.
Clinical Colorectal Cancer|June 6, 2018
Prognostic and Predictive Value of HER2 Amplification in Patients With Metastatic Colorectal CancerKentaro Sawada, Yoshiaki Nakamura, Takeharu Yamanaka, et al.
Angiology|November 28, 2018
Evaluation of Risk Factors for Limb-Specific Peripheral Vascular Events in Patients With Peripheral Artery Disease: A Post Hoc Analysis of the SEASON Prospective Observational StudyTetsuro Miyata, Yukihito Higashi, Hiroshi Shigematsu, et al.
Japanese Journal of Clinical Oncology|March 23, 2010
Phase II study of combination chemotherapy with biweekly cetuximab and irinotecan for pre-treated metastatic colorectal cancer harboring wild-type KRASKohei Shitara, Tomoya Yokota, Daisuke Takahari, et al.
Japanese Journal of Clinical Oncology|October 17, 2012
Clinical outcome of Japanese metastatic colorectal cancer patients harbouring the KRAS p.G13D mutation treated with cetuximab + irinotecanHideaki Bando, Takayuki Yoshino, Satoshi Yuki, et al.
Advances in Therapy|June 19, 2010
Phase 1/2 clinical study of irinotecan and oral S-1 (IRIS) in patients with advanced gastric cancerYoshito Komatsu, Satoshi Yuki, Nozomu Fuse, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 25, 2010
[A case of sigmoid colon cancer with lymphangitis carcinomatosa successfully treated with chemotherapies including molecular targeting drugs]Susumu Sogabe, Satoshi Yuki, Tomofumi Takagi, et al.
BMC Cancer|March 23, 2019
Comparative sequence analysis of patient-matched primary colorectal cancer, metastatic, and recurrent metastatic tumors after adjuvant FOLFOX chemotherapyKazuaki Harada, Wataru Okamoto, Sachiyo Mimaki, et al.
Pageof 12